Sorin Group Announces FDA 510(k) Clearance For The New Sorin Connect Perfusion Charting System

barbara.lempert

Milan, July 30, 2013 – , (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the 510(k) for commercialization of CONNECTTM, Group’s new innovative and intuitive electronic .
 
The new Sorin perfusion electronic charting system allows real-time data recording and trends visualization aimed to support clinicians and institutions in their perfusion management and documentation goals, during and after cardiac surgery. During the surgical case, all relevant information related to the patient and perfusion are electronically collected from Sorin’s heart lung machines and autotransfusion systems, as well as a variety of other patient monitoring devices, allowing the creation of an electronic medical record for each patient. After surgery, statistical tools are easily available for queries and analysis, supporting clinicians’ efforts towards hospital quality management and practice improvement programs.
Electronic Medical Records (EMR) have been proven to improve quality of patient care, decrease human errors associated with medical practice and control healthcare expenditures. Adoption of Electronic Medical Records (EMR) is expected to significantly and rapidly increase in the near future, starting with the United States. The Obama administration mandated to have all medical records in the United States converted to the electronic format by 2014. While the United States are early adopters of digital technologies and will continue to drive adoption faster than other geographies, due to the rapidly changing health care scenario, Europe and emerging countries are expected to follow closely.
 
“CONNECT makes data management during Cardiopulmonary simple and the addition of GDP MonitorTM (Goal Directed Perfusion) offers a new level of physiological control in line with Goal Directed Therapy”, said Paul…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS